Xanthus Pharmaceuticals, Inc.
Reports describe the most recent news from Xanthus Pharmaceuticals, Inc.
Published in Healthcare Finance, Tax and Law Weekly, August 22nd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Xanthus Pharmaceuticals, Inc.
Report 1: Xanthus Pharmaceuticals, Inc. announced the presentation of Phase 1 data from a study of P2045 conducted by Bayer Schering Pharma AG (formerly Schering AG) in patients with advanced lung cancer. The Company holds an exclusive license to P2045 from Schering AG. The presentation was made in a poster session at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO). In the study, a single dose of P2045 was well tolerated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Aarp
Seniors Set to be Hit Hard by Illinois Budget - Americans United for Life
Kansas Abortionist Tiller's Claims Without Merit Americans United for Life Amicus Brief Says - Amyotrophic Lateral Sclerosis
New findings from Columbia University in the area of amyotrophic lateral sclerosis published - Atrium Innovations INC.
Atrium Continues its Growth with a 5% Increase in Net Earnings for the Second Quarter of 2007 - ATS Medical, Inc.
ATS Promotes Michael Kramer to CFO Role - AVANIR Pharmaceuticals
AVANIR Pharmaceuticals Completes Sale of FazaClo - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
